TANYA KIRPALANI: Open Payments
NPI 1982993143 · CLERMONT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,572 in 81 payments from 24 companies in 2025. Trend: 2023 $1,870 · 2024 $1,940 · 2025 $1,572
Food & beverage: $1,572
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $224 |
| ABBVIE INC. | 11 | $216 |
| AstraZeneca Pharmaceuticals LP | 10 | $206 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $105 |
| Exact Sciences Corporation | 4 | $86 |
| Axsome Therapeutics, Inc. | 3 | $83 |
| GlaxoSmithKline, LLC. | 4 | $78 |
| Lilly USA, LLC | 4 | $75 |
| Amgen Inc. | 4 | $70 |
| PFIZER INC. | 3 | $62 |
Products named: FARXIGA, Ozempic, CAPLYTA, Wegovy, UBRELVY, VRAYLAR, MOUNJARO, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
